Chesley Taft & Associates LLC Eli Lilly & CO Transaction History

Chesley Taft & Associates LLC

$2.05 Billion
Q1 2025

A detailed history of Chesley Taft & Associates LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Chesley Taft & Associates LLC holds 23,035 shares of LLY stock, worth $18.9 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares

23,035

Previous 22,323 3.19%

Holding current value

$18.9 Million

Previous $17.2 Million 10.39%

% of portfolio

0.93%

Previous 0.81%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 10, 2025	BUY	$725.72 - $929.72 $516,712 - $661,960	712 Added 3.19%	23,035 $19 Million
Q4 2024 Jan 16, 2025	SELL	$727.2 - $932.06 $43,632 - $55,923	-60 Reduced 0.27%	22,323 $17.2 Million
Q3 2024 Oct 07, 2024	SELL	$772.14 - $960.02 $131,263 - $163,203	-170 Reduced 0.75%	22,383 $19.8 Million
Q2 2024 Jul 19, 2024	BUY	$724.87 - $909.04 $843,023 - $1.06 Million	1,163 Added 5.44%	22,553 $20.4 Million
Q1 2024 Apr 15, 2024	SELL	$592.2 - $792.28 $74,025 - $99,035	-125 Reduced 0.58%	21,390 $16.6 Million
Q4 2023 Jan 11, 2024	BUY	$525.19 - $619.13 $2.03 Million - $2.39 Million	3,864 Added 21.89%	21,515 $12.5 Million
Q3 2023 Oct 10, 2023	SELL	$434.7 - $599.3 $400,793 - $552,554	-922 Reduced 4.96%	17,651 $9.48 Million
Q2 2023 Jul 17, 2023	SELL	$350.74 - $468.98 $534,527 - $714,725	-1,524 Reduced 7.58%	18,573 $8.71 Million
Q1 2023 Apr 11, 2023	SELL	$310.63 - $364.82 $124,562 - $146,292	-401 Reduced 1.96%	20,097 $6.9 Million
Q4 2022 Jan 19, 2023	SELL	$321.55 - $374.67 $828,634 - $965,524	-2,577 Reduced 11.17%	20,498 $0
Q3 2022 Oct 13, 2022	BUY	$296.48 - $337.87 $38,542 - $43,923	130 Added 0.57%	23,075 $7.46 Million
Q2 2022 Jul 07, 2022	BUY	$278.73 - $327.27 $55,746 - $65,454	200 Added 0.88%	22,945 $7.44 Million
Q1 2022 Apr 14, 2022	BUY	$234.69 - $291.66 $2,346 - $2,916	10 Added 0.04%	22,745 $7.01 Million
Q4 2021 Jan 05, 2022	BUY	$224.85 - $279.04 $14,615 - $18,137	65 Added 0.29%	22,735 $6.28 Million
Q3 2021 Oct 05, 2021	BUY	$221.6 - $272.71 $91,964 - $113,174	415 Added 1.86%	22,670 $5.24 Million
Q2 2021 Jul 07, 2021	BUY	$180.55 - $233.54 $19,860 - $25,689	110 Added 0.5%	22,255 $5.11 Million
Q1 2021 Apr 06, 2021	BUY	$164.32 - $212.72 $41,080 - $53,180	250 Added 1.14%	22,145 $4.09 Million
Q4 2020 Jan 11, 2021	SELL	$130.46 - $172.63 $56,097 - $74,230	-430 Reduced 1.93%	21,895 $3.7 Million
Q3 2020 Oct 08, 2020	SELL	$146.22 - $169.13 $131,598 - $152,217	-900 Reduced 3.88%	22,325 $3.31 Million
Q2 2020 Jul 08, 2020	BUY	$136.42 - $164.18 $79,805 - $96,045	585 Added 2.58%	23,225 $3.81 Million
Q1 2020 Apr 15, 2020	BUY	$119.05 - $147.35 $175,598 - $217,341	1,475 Added 6.97%	22,640 $3.14 Million
Q4 2019 Jan 10, 2020	BUY	$106.92 - $132.43 $25,660 - $31,783	240 Added 1.15%	21,165 $2.78 Million
Q3 2019 Oct 07, 2019	SELL	$106.79 - $116.16 $59,802 - $65,049	-560 Reduced 2.61%	20,925 $2.34 Million
Q2 2019 Jul 10, 2019	BUY	$110.79 - $129.32 $13,848 - $16,165	125 Added 0.59%	21,485 $2.38 Million
Q1 2019 Apr 05, 2019	BUY	$111.31 - $131.02 $174,756 - $205,701	1,570 Added 7.93%	21,360 $2.77 Million
Q4 2018 Jan 07, 2019	BUY	$105.9 - $118.64 $1.68 Million - $1.88 Million	15,870 Added 404.85%	19,790 $2.29 Million
Q3 2018 Oct 12, 2018	SELL	$85.86 - $107.31 $30,051 - $37,558	-350 Reduced 8.2%	3,920 $421,000
Q2 2018 Jul 12, 2018	SELL	$75.7 - $86.88 $28,766 - $33,014	-380 Reduced 8.17%	4,270 $364,000
Q1 2018 Apr 11, 2018	SELL	$74.21 - $87.6 $28,125 - $33,200	-379 Reduced 7.54%	4,650 $360,000
Q4 2017 Jan 10, 2018	SELL	$81.94 - $87.89 $1,147 - $1,230	-14 Reduced 0.28%	5,029 $425,000
Q3 2017 Oct 13, 2017	BUY	$77.07 - $85.54 $388,664 - $431,378	5,043	5,043 $431,000

Others Institutions Holding LLY

# of Institutions

4,375

Shares Held

812M

Call Options Held

9.97M

Put Options Held

11.4M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $781B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chesley Taft & Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chesley Taft & Associates LLC with notifications on news.

Account

Chesley Taft & Associates LLC Eli Lilly & CO Transaction History